Genetic polymorphisms of cytochrome P450c17 alpha (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risk

Página do item simplificado
dc.contributor.authorCarvalho, Cristina Valletta de [UNIFESP]
dc.contributor.authorNogueira-de-Souza, Naiara Corrêa [UNIFESP]
dc.contributor.authorCosta, Ana Maria Massad [UNIFESP]
dc.contributor.authorBaracat, Edmund Chada [UNIFESP]
dc.contributor.authorGirão, Manoel João Batista [UNIFESP]
dc.contributor.authorD'Amora, Paulo [UNIFESP]
dc.contributor.authorSchor, Eduardo [UNIFESP]
dc.contributor.authorSilva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.date.accessioned2016-01-24T12:41:45Z
dc.date.available2016-01-24T12:41:45Z
dc.date.issued2007-01-01
dc.description.abstractWe designed the present study in order to evaluate the eventual role of polymorphisms in the genes encoding cytochrome P450c17 alpha (CYP17) and the progesterone receptor (PROGINS) as risk factors for endometriosis development. Eligible cases consisted of 121 women with surgically confirmed endometriosis who underwent treatment in a hospital in São Paulo, Brazil during the period from September 2003 to September 2005. the 281 controls were participants with normal gynecological as well as pelvic ultrasound evaluation, who did not have any gynecological conditions during their reproductive lives such as pelvic pain and/or dyspareunia nor infertility history. Genomic DNA was obtained from buccal cells and processed for DNA extraction using the GFX DNA extraction kit (GE Healthcare). the CYP17 (- 34T-->C) polymerase chain reaction-restriction fragment length polymorphism assay has been described previously, as has the progesterone receptor polymorphism (PROGINS) detection assay. PROGINS heterozygosis genotype frequencies were shown to be statistically higher in endometriosis cases compared with controls. On the other hand, differences in the CYP17 polymorphism (- 34T --> C) frequencies were not even close to significance (p = 0.278) according to our findings.en
dc.description.affiliationUniversidade Federal de São Paulo, Dept Gynecol, Mol Gynecol Lab, BR-04039032 São Paulo, Brazil
dc.description.affiliationUniversidade Federal de São Paulo, Dept Gynecol, São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Gynecol, Mol Gynecol Lab, BR-04039032 São Paulo, Brazil
dc.description.affiliationUnifespUniversidade Federal de São Paulo, Dept Gynecol, São Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent29-33
dc.identifierhttp://dx.doi.org/10.1080/09513590601024707
dc.identifier.citationGynecological Endocrinology. Lancaster: Parthenon Publishing Group, v. 23, n. 1, p. 29-33, 2007.
dc.identifier.doi10.1080/09513590601024707
dc.identifier.issn0951-3590
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/29404
dc.identifier.wosWOS:000244100200005
dc.language.isoeng
dc.publisherParthenon Publishing Group
dc.relation.ispartofGynecological Endocrinology
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectendometriosisen
dc.subjectCYP17en
dc.subjectprogesterone receptoren
dc.subjectpolymorphismen
dc.titleGenetic polymorphisms of cytochrome P450c17 alpha (CYP17) and progesterone receptor genes (PROGINS) in the assessment of endometriosis risken
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos